Voyager Therapeutics Inc.
(VYGR)
undefined
undefined%
At close: undefined
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
| Net Income | 132.33M | -46.41M | -71.20M | 36.74M | -43.60M | -88.29M | -70.70M | -40.19M | -29.67M | -16.32M | -7.67M |
| Depreciation & Amortization | 4.44M | 6.19M | 5.17M | 3.82M | 2.77M | 2.12M | 1.59M | 612.00K | 600.00K | 184.00K | n/a |
| Stock-Based Compensation | 11.15M | 9.34M | 11.32M | 14.93M | 15.64M | 15.71M | 9.24M | 6.31M | 4.03M | 425.00K | n/a |
| Other Working Capital | 17.64M | 18.00M | -1.72M | -150.68M | 80.83M | 55.66M | -2.60M | -12.79M | 57.08M | -127.00K | 182.00K |
| Other Non-Cash Items | -3.45M | -2.11M | -2.46M | -7.70M | -996.00K | 1.36M | 674.00K | 2.94M | 9.75M | 3.31M | 2.03M |
| Deferred Income Tax | n/a | n/a | 349.00K | 27.00K | -3.58M | -2.16M | -24.00K | 696.00K | 452.00K | n/a | n/a |
| Change in Working Capital | -66.56M | 20.47M | 3.29M | -144.54M | 78.44M | 55.38M | -2.13M | -12.85M | 56.14M | 477.00K | 182.00K |
| Operating Cash Flow | 77.92M | -12.51M | -53.52M | -96.72M | 48.67M | -15.89M | -61.35M | -42.48M | 41.30M | -11.92M | -5.45M |
| Capital Expenditures | -3.26M | -2.49M | -1.61M | -12.10M | -7.72M | -4.30M | -3.98M | -5.03M | -1.03M | -2.99M | n/a |
| Acquisitions | 138.39M | 4.85M | -2.46M | -7.70M | 172.00K | n/a | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | -223.97M | -54.85M | -15.12M | -70.40M | -494.23M | -333.23M | -147.30M | -112.35M | -220.40M | n/a | n/a |
| Sales Maturities Of Investments | 85.58M | 50.00M | 82.63M | 195.50M | 411.30M | 364.00M | 147.60M | 165.10M | 26.66M | n/a | n/a |
| Other Investing Acitivies | -138.39M | -4.85M | 2.46M | 7.70M | -82.76M | 30.77M | 304.00K | -421.00K | -193.74M | -314.00K | n/a |
| Investing Cash Flow | -141.64M | -7.34M | 65.91M | 113.00M | -90.48M | 26.47M | -3.68M | 47.30M | -194.77M | -3.30M | n/a |
| Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Common Stock Repurchased | n/a | 481.00K | 584.00K | 844.00K | n/a | 860.00K | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 2.52M | 1.11M | 612.00K | 3.16M | 3.38M | 4.75M | 1.93M | 514.00K | 177.73M | 44.16M | 5.72M |
| Financial Cash Flow | 33.65M | 1.11M | 612.00K | 3.16M | 80.99M | 4.75M | 59.92M | 514.00K | 177.74M | 22.12M | 5.72M |
| Net Cash Flow | -30.08M | -18.74M | 12.99M | 19.44M | 39.18M | 15.33M | -5.11M | 5.33M | 24.27M | 6.90M | 270.00K |
| Free Cash Flow | 74.66M | -15.00M | -55.13M | -108.81M | 40.95M | -20.19M | -65.33M | -47.51M | 40.27M | -14.91M | -5.45M |